NCT05851651

Brief Summary

Exclusive breastfeeding is global recognized as the optimal infant feeding. Hong Kong is committed to promoting, protecting and supporting the global movement for successful breastfeeding. Exclusive breastfeeding is especially strongly recommended and supported to the maternal history of Gestational Diabetes Mellitus (GDM). This study aims to examine the acceptability and feasibility of Antenatal human milk expression (AME) as breastfeeding intervention to improve breastfeeding for GDM women. The efficacy of AME practice on the breastfeeding exclusivity will also be investigated. It is hypothesized that AME will increase breastfeeding exclusivity compare with women receiving standard care, and will improve the breastfeeding self-efficacy and reduce depressive symptoms of women after birth.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
246

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2023

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 17, 2023

Completed
23 days until next milestone

First Posted

Study publicly available on registry

May 10, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

May 10, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 10, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 10, 2024

Completed
Last Updated

September 19, 2024

Status Verified

April 1, 2023

Enrollment Period

1 year

First QC Date

April 17, 2023

Last Update Submit

September 11, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Infant Feeding pattern

    Exclusive breastfeeding prevalence

    At 4 weeks postpartum

  • Infant Feeding pattern

    Exclusive breastfeeding prevalence

    At 8 weeks postpartum

Secondary Outcomes (4)

  • Women's self-determination toward breastfeeding

    At baseline, 4 weeks and 8 weeks postpartum

  • Women's self-efficacy in breastfeeding

    At baseline, 4 weeks and 8 weeks postpartum

  • Women's perinatal/postnatal depression

    At baseline, 4 weeks and 8 weeks postpartum

  • Women's prevalence of Impaired Glucose Tolerance

    At 6 weeks postpartum

Other Outcomes (1)

  • Women's experience, perception, and attitude for AME practices

    At 6 weeks postpartum

Study Arms (2)

Standard care plus an antenatal milk expression education

EXPERIMENTAL

Participants will have one face-to-face breastfeeding education in lactation clinic at 37 weeks of gestation and telephone follow-up weekly till delivery.

Behavioral: Antenatal milk expression and breastfeeding self-efficacy enhancement

Standard hospital antenatal care

NO INTERVENTION

Participants will receive standard care include prenatal breastfeeding education at gestation of 24-36 weeks same as intervention group. They will not discuss about antenatal milk expression, breastfeeding self-efficacy and the effects of breastfeeding on GDM women.

Interventions

A face-to-face breastfeeding education in lactation clinic at 37 weeks of gestation will be arranged. The session will approximately last for 45minutes. GDM leaflet and GAME fact sheet are used to facilitate the teaching. The benefits of breastfeeding for women with GDM will be addressed. Maternal metabolic control, calories consumed, and weight loss are addressed for the extra benefits of breastfeeding for GDM women. The possible challenges of GDM on breastfeeding will be supported. The antenatal human milk expression will be taught by International Board-Certified Lactation Consultant. Participants will be encouraged to express colostrum twice daily for up to 10 minutes until admitted to hospital to give birth. They will receive a weekly phone follows up from 38 weeks before delivery and they can contact the researcher by phone in the information sheet if any questions.

Standard care plus an antenatal milk expression education

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosed gestational diabetes without on insulin
  • can read and speak Chinese
  • Hong Kong resident and stay in Hong Kong after delivery
  • no serious medical or obstetrical complications
  • no mental health illness or history
  • have regular antenatal check-up
  • singleton pregnancy
  • primiparous or multiparous women
  • intention to breastfeed
  • pre-pregnancy BMI\<25

You may not qualify if:

  • do not have Hong Kong Identify Card
  • breastfeeding elder child at pregnancy
  • cannot understand the study
  • give birth \<37 weeks of gestation
  • a known fetal anomaly or any suspicion of fetal compromise

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Kwong Wah Hospital

Hong Kong, Hong Kong

Location

Queen Elizabeth Hospital

Hong Kong, Hong Kong

Location

MeSH Terms

Conditions

Breast Feeding

Condition Hierarchy (Ancestors)

Feeding BehaviorBehavior

Study Officials

  • Yu Ngai Ms Leung, MPH

    Department of Obstetrics and Gynaecology, Kwong Wah Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 17, 2023

First Posted

May 10, 2023

Study Start

May 10, 2023

Primary Completion

May 10, 2024

Study Completion

May 10, 2024

Last Updated

September 19, 2024

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations